The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021
Nephrology Dialysis Transplantation · 28.02.2023 · 38 (3) · 551-561
DOI: 10.1093/ndt/gfab351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 09.12.2021. Verfasst von Hans-Joachim Anders und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Munich, Germany. Hauptthemen laut MEDLINE: Lupus Nephritis, Glomerulonephritis, Membranous. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: ERA, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
In 2019 and 2021, the European League for Rheumatism (EULAR) jointly with the European Renal Association (ERA) and the Kidney Disease: Improving Global Outcomes (KDIGO), respectively, released updated guidelines on the management of lupus nephritis (LN). The Immunology Working Group of the ERA reviewed and compared both updates. Recommendations were either consistent or differences were of negligible clinical relevance for: indication for kidney biopsy, kidney biopsy interpretation, treatment targets, hydroxychloroquine dosing, first-line initial immunosuppressive therapy for active class III, IV (±V) LN, pregnancy in LN, LN in paediatric patients and LN patients with kidney failure. Relevant differences in the recommended management relate to the recognition of lupus podocytopathies, uncertainties in steroid dosing, drug preferences in specific populations and maintenance therapy, treatment of pure class V LN, therapy of recurrent LN, evolving alternative drug options and diagnostic work-up of thrombotic microangiopathy. Altogether, both documents provide an excellent guidance to the growing complexity of LN management. This article endeavours to prevent confusion by identifying differences and clarifying discrepancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Munich, Germany.
- Department of Health, Medicine and Caring Sciences, Division of Diagnostics and Specialist Medicine, Linköping University, Linköping, Sweden.
- Department of Clinical Science, Intervention and Technology, Division of Renal Medicine, Karolinska Institutet, Stockholm, Sweden.
- Department of Nephrology, Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain.
- Division of Nephrology, RWTH Aachen University Hospital, Aachen, Germany.
- Department of Nephrology and Renal Transplantation, Patras University Hospital, Patras, Greece.
ORCID-Profile: Annette Bruchfeld, Gema M Fernández-Juárez, Kate I Stevens
Förderung
- ERA
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Anders, H. J., Loutan, J., Bruchfeld, A., Fernández-Juárez, G. M., Floege, J., Goumenos, D., Turkmen, K., van Kooten, C., Frangou, E., Stevens, K. I., Kronbichler, A., Segelmark, M., & Tesar, V. (2023). The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021. Nephrology Dialysis Transplantation, 38(3), 551-561. https://doi.org/10.1093/ndt/gfab351
Vancouver
Anders HJ, Loutan J, Bruchfeld A, Fernández-Juárez GM, Floege J, Goumenos D, et al. The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021. Nephrology Dialysis Transplantation. 2023;38(3):551-561. doi:10.1093/ndt/gfab351
BibTeX
@article{Anders2023,
author = {Anders, Hans-Joachim and Loutan, Jerome and Bruchfeld, Annette and Fernández-Juárez, Gema M and Floege, Jürgen and Goumenos, Dimitrios and Turkmen, Kultigin and van Kooten, Cees and Frangou, Eleni and Stevens, Kate I and Kronbichler, Andreas and Segelmark, Mårten and Tesar, Vladimir},
title = {The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021},
journal = {Nephrology Dialysis Transplantation},
year = {2023},
volume = {38},
number = {3},
pages = {551--561},
doi = {10.1093/ndt/gfab351}
}
EUVIMED